Correlation Between Cingulate Warrants and Vyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Vyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Vyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Vyne Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Vyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Vyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Vyne Therapeutics.

Diversification Opportunities for Cingulate Warrants and Vyne Therapeutics

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cingulate and Vyne is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Vyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vyne Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Vyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vyne Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Vyne Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Vyne Therapeutics

Assuming the 90 days horizon Cingulate Warrants is expected to generate 30.98 times more return on investment than Vyne Therapeutics. However, Cingulate Warrants is 30.98 times more volatile than Vyne Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Vyne Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  2.50  in Cingulate Warrants on September 12, 2024 and sell it today you would earn a total of  1.13  from holding Cingulate Warrants or generate 45.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy78.23%
ValuesDaily Returns

Cingulate Warrants  vs.  Vyne Therapeutics

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Vyne Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cingulate Warrants and Vyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and Vyne Therapeutics

The main advantage of trading using opposite Cingulate Warrants and Vyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Vyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vyne Therapeutics will offset losses from the drop in Vyne Therapeutics' long position.
The idea behind Cingulate Warrants and Vyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine